240 related articles for article (PubMed ID: 10579848)
21. Synthesis of new 2,4-Diaminopyrido[2,3-d]pyrimidine and 2,4-Diaminopyrrolo[2,3-d]pyrimidine inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductase.
Rosowsky A; Chen H; Fu H; Queener SF
Bioorg Med Chem; 2003 Jan; 11(1):59-67. PubMed ID: 12467708
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of biguanide and dihydrotriazine derivatives as potential inhibitors of dihydrofolate reductase of opportunistic microorganisms.
Bag S; Tawari NR; Queener SF; Degani MS
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):331-9. PubMed ID: 19874136
[TBL] [Abstract][Full Text] [Related]
23. Structural analysis of a holoenzyme complex of mouse dihydrofolate reductase with NADPH and a ternary complex with the potent and selective inhibitor 2,4-diamino-6-(2'-hydroxydibenz[b,f]azepin-5-yl)methylpteridine.
Cody V; Pace J; Rosowsky A
Acta Crystallogr D Biol Crystallogr; 2008 Sep; 64(Pt 9):977-84. PubMed ID: 18703847
[TBL] [Abstract][Full Text] [Related]
24. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines.
Gangjee A; Adair O; Queener SF
J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486
[TBL] [Abstract][Full Text] [Related]
25. Nonclassical 2,4-diamino-8-deazafolate analogues as inhibitors of dihydrofolate reductases from rat liver, Pneumocystis carinii, and Toxoplasma gondii.
Gangjee A; Zhu Y; Queener SF; Francom P; Broom AD
J Med Chem; 1996 Apr; 39(9):1836-45. PubMed ID: 8627607
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological activities of conformationally restricted, tricyclic nonclassical antifolates as inhibitors of dihydrofolate reductases.
Gangjee A; Shi J; Queener SF
J Med Chem; 1997 Jun; 40(12):1930-6. PubMed ID: 9191971
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
Rosowsky A; Hynes JB; Queener SF
Antimicrob Agents Chemother; 1995 Jan; 39(1):79-86. PubMed ID: 7695334
[TBL] [Abstract][Full Text] [Related]
28. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens.
Bag S; Tawari NR; Degani MS; Queener SF
Bioorg Med Chem; 2010 May; 18(9):3187-97. PubMed ID: 20363634
[TBL] [Abstract][Full Text] [Related]
30. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
Robson C; Meek MA; Grunwaldt JD; Lambert PA; Queener SF; Schmidt D; Griffin RJ
J Med Chem; 1997 Sep; 40(19):3040-8. PubMed ID: 9301666
[TBL] [Abstract][Full Text] [Related]
31. 6,7-disubstituted 2,4-diaminopteridines: novel inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
Jackson HC; Biggadike K; McKilligin E; Kinsman OS; Queener SF; Lane A; Smith JE
Antimicrob Agents Chemother; 1996 Jun; 40(6):1371-5. PubMed ID: 8726003
[TBL] [Abstract][Full Text] [Related]
32. Effect of N9-methylation and bridge atom variation on the activity of 5-substituted 2,4-diaminopyrrolo[2,3-d]pyrimidines against dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
Gangjee A; Mavandadi F; Queener SF
J Med Chem; 1997 Mar; 40(7):1173-7. PubMed ID: 9089339
[TBL] [Abstract][Full Text] [Related]
33. Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium.
Forsch RA; Queener SF; Rosowsky A
Bioorg Med Chem Lett; 2004 Apr; 14(7):1811-5. PubMed ID: 15026078
[TBL] [Abstract][Full Text] [Related]
34. 2,4-Diaminothieno[2,3-d]pyrimidine analogues of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
Rosowsky A; Mota CE; Wright JE; Freisheim JH; Heusner JJ; McCormack JJ; Queener SF
J Med Chem; 1993 Oct; 36(21):3103-12. PubMed ID: 8230096
[TBL] [Abstract][Full Text] [Related]
35. Structural analysis of human dihydrofolate reductase as a binary complex with the potent and selective inhibitor 2,4-diamino-6-{2'-O-(3-carboxypropyl)oxydibenz[b,f]-azepin-5-yl}methylpteridine reveals an unusual binding mode.
Cody V; Pace J; Nowak J
Acta Crystallogr D Biol Crystallogr; 2011 Oct; 67(Pt 10):875-80. PubMed ID: 21931219
[TBL] [Abstract][Full Text] [Related]
36. Kinetic and structural analysis for potent antifolate inhibition of Pneumocystis jirovecii, Pneumocystis carinii, and human dihydrofolate reductases and their active-site variants.
Cody V; Pace J; Queener SF; Adair OO; Gangjee A
Antimicrob Agents Chemother; 2013 Jun; 57(6):2669-77. PubMed ID: 23545530
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
Gangjee A; Adair O; Queener SF
Bioorg Med Chem; 2001 Nov; 9(11):2929-35. PubMed ID: 11597474
[TBL] [Abstract][Full Text] [Related]
38. 2,4-Diamino-5-chloroquinazoline analogues of trimetrexate and piritrexim: synthesis and antifolate activity.
Rosowsky A; Mota CE; Wright JE; Queener SF
J Med Chem; 1994 Dec; 37(26):4522-8. PubMed ID: 7799402
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and dihydrofolate reductase inhibitory activities of 2,4-diamino-5-deaza and 2,4-diamino-5,10-dideaza lipophilic antifolates.
Gangjee A; Devraj R; Queener SF
J Med Chem; 1997 Feb; 40(4):470-8. PubMed ID: 9046337
[TBL] [Abstract][Full Text] [Related]
40. Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis.
Hopper AT; Brockman A; Wise A; Gould J; Barks J; Radke JB; Sibley LD; Zou Y; Thomas S
J Med Chem; 2019 Feb; 62(3):1562-1576. PubMed ID: 30624926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]